Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Can Zytiga Build on a Historic 2012?
Motley Fool
Wednesday, February 20, 2013 - 11:40am
tags:
Zytiga, JNJ, prostate cancer
Will Isis Right Pfizer's Wrong?
Motley Fool
Wednesday, February 20, 2013 - 11:33am
tags:
Pfizer, Isis Pharmaceuticals, Kynamro, generics
Ziopharm: What Happens Next?
Seeking Alpha
Tuesday, February 19, 2013 - 3:28pm
tags:
Ziopharm, palifosfamide
FDA OKs Novartis Drug to Fight Liver Transplant Rejection
Motley Fool
Tuesday, February 19, 2013 - 3:25pm
tags:
liver transplant, Novartis, FDA, Zortress
Gilead hepatitis C drug meets goal of 4th late-stage study
Reuters
Tuesday, February 19, 2013 - 3:24pm
tags:
hepatitis C, Gilead, sofosbuvir
J&J Jury Begins Deliberating in First Vaginal Mesh Trial
Bloomberg
Tuesday, February 19, 2013 - 3:15pm
tags:
JNJ, vaginal mesh
BioMarin Earnings: An Early Look
Motley Fool
Tuesday, February 19, 2013 - 3:14pm
tags:
earnings, Biomarin
Osiris Therapeutics Successfully Defends Key Stem Cell Patent Challenge
Yahoo
Tuesday, February 19, 2013 - 10:18am
tags:
stem cells, Osiris Therapeutics, patents, Prochymal
Amgen's Future Is Brighter Than You Might Think
Motley Fool
Tuesday, February 19, 2013 - 10:13am
tags:
Amgen
Stocks Could Rise For Companies Investing In Immunotherapy Treatments
Seeking Alpha
Tuesday, February 19, 2013 - 10:12am
tags:
immunotherapy, Celgene, Bristol-Myers Squibb, OncoSec, ONYX Pharmaceuticals, Vical
Takeda Faces First Trial Over Actos Diabetes Drug in L.A.
Bloomberg
Tuesday, February 19, 2013 - 10:11am
tags:
Takeda, Actos, diabetes
Quintiles Confirms 'Go Public' Speculation with IPO and Predicts Rosy Future for CROs
Outsourcing Pharma
Tuesday, February 19, 2013 - 10:08am
tags:
IPOs, Quintiles, CROs
Why Forest Laboratories May Be About to Take Off
Motley Fool
Tuesday, February 19, 2013 - 10:07am
tags:
Forest Labs
Rexahn says to continue RX-3117 development with Teva
The Fly on the Wall
Tuesday, February 19, 2013 - 10:07am
tags:
Rexahn, RX-3117, Teva, RX-5902, Archexin
Will Sequester End Drug Approvals? Not Unless White House Wants it to
Forbes
Tuesday, February 19, 2013 - 10:05am
tags:
FDA, drug approvals
Vioxx and Diclofenac: Why Are Two Heart Risky Pain Drugs Viewed Differently?
Forbes
Tuesday, February 19, 2013 - 10:04am
tags:
Vioxx, diclofenac, Merck, Celebrex, Voltaren
4 Healthcare Stock Stories Starting Off the Short Week
Wall St. Cheat Sheet
Tuesday, February 19, 2013 - 9:58am
tags:
Novartis, AbbVie, St. Jude Medical, Amicus Therapeutics
Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
Yahoo
Tuesday, February 19, 2013 - 9:54am
tags:
lixisenatide, Sanofi, FDA, diabetes, GLP-1 receptor
A Legit Reason To Give Amicus' Fabry Drug Another Chance
TheStreet.com
Tuesday, February 19, 2013 - 9:51am
tags:
Amicus, Fabry's disease, Amigal
Merck: Enjoy This Generous Yield
Seeking Alpha
Tuesday, February 19, 2013 - 9:46am
tags:
Merck

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.